FDA)-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine methyl bromide syrupHi – Tech Pharmacal Co. announced that the U.S. Has Food and Drug Administration approval of the Company issued Abbreviated New Drug Application for hydrocodone Bitartrate and Homatropine methylbromide syrup. The generic equivalent of Endo Pharmaceuticals Hycoda Hydrocodone Bitartrate and Homatropine methylbromide syrup is indicated for the symptomatic relief of cough and had sales of approximately after 5 million for. The Company expects to begin marketing the product immediately.
During the past two decades , several studies have shown that new neurons generated in the hippocampus In animal studies the problem of nerve cell generation of in the loss of the memory function, resulted in a simultaneous increase in the production of new nerve cells to improved memory.Checking performs data from 19 clinical trials with 2 554 patient with an array of different wounds. Honey was view more effective at reducing healing time compared to some of gauze film dressings which have which are commonly used to address moderate burns. However, the researchers could reveal no in the position any clear advantages for healing of skinned, lacerations, surgical wounds and leg ulcers.